Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2893787034;87035;87036 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
N2AB2729682111;82112;82113 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
N2A2636979330;79331;79332 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
N2B1987259839;59840;59841 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
Novex-11999760214;60215;60216 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
Novex-22006460415;60416;60417 chr2:178559323;178559322;178559321chr2:179424050;179424049;179424048
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Fn3-98
  • Domain position: 93
  • Structural Position: 127
  • Q(SASA): 0.281
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs794727453 None None N 0.194 0.084 0.41337360676 gnomAD-3.1.2 3.29E-05 None None None None N None 1.20633E-04 0 0 0 0 None 0 0 0 0 0
V/I rs794727453 None None N 0.194 0.084 0.41337360676 gnomAD-4.0.0 7.9363E-06 None None None None N None 1.0376E-04 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.2469 likely_benign 0.2146 benign -1.342 Destabilizing 0.088 N 0.464 neutral N 0.490239373 None None N
V/C 0.6184 likely_pathogenic 0.6011 pathogenic -0.639 Destabilizing 0.981 D 0.595 neutral None None None None N
V/D 0.6631 likely_pathogenic 0.6478 pathogenic -1.67 Destabilizing 0.842 D 0.713 prob.delet. None None None None N
V/E 0.4405 ambiguous 0.4334 ambiguous -1.448 Destabilizing 0.395 N 0.617 neutral N 0.490999841 None None N
V/F 0.1773 likely_benign 0.1762 benign -0.764 Destabilizing 0.801 D 0.589 neutral None None None None N
V/G 0.3323 likely_benign 0.3251 benign -1.825 Destabilizing 0.609 D 0.686 prob.delet. N 0.49150682 None None N
V/H 0.6298 likely_pathogenic 0.62 pathogenic -1.454 Destabilizing 0.985 D 0.749 deleterious None None None None N
V/I 0.0647 likely_benign 0.0663 benign -0.007 Destabilizing None N 0.194 neutral N 0.493599 None None N
V/K 0.4081 ambiguous 0.4173 ambiguous -0.952 Destabilizing 0.654 D 0.633 neutral None None None None N
V/L 0.1862 likely_benign 0.1809 benign -0.007 Destabilizing 0.005 N 0.462 neutral N 0.510221891 None None N
V/M 0.1215 likely_benign 0.1153 benign -0.015 Destabilizing 0.742 D 0.51 neutral None None None None N
V/N 0.4349 ambiguous 0.4203 ambiguous -1.352 Destabilizing 0.219 N 0.728 deleterious None None None None N
V/P 0.9131 likely_pathogenic 0.9187 pathogenic -0.425 Destabilizing 0.363 N 0.615 neutral None None None None N
V/Q 0.3703 ambiguous 0.3619 ambiguous -1.156 Destabilizing 0.731 D 0.669 prob.neutral None None None None N
V/R 0.3873 ambiguous 0.3908 ambiguous -0.948 Destabilizing 0.801 D 0.755 deleterious None None None None N
V/S 0.3219 likely_benign 0.2927 benign -1.917 Destabilizing 0.237 N 0.583 neutral None None None None N
V/T 0.1932 likely_benign 0.1596 benign -1.547 Destabilizing 0.001 N 0.16 neutral None None None None N
V/W 0.7823 likely_pathogenic 0.7798 pathogenic -1.222 Destabilizing 0.996 D 0.769 deleterious None None None None N
V/Y 0.531 ambiguous 0.5407 ambiguous -0.742 Destabilizing 0.891 D 0.61 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.